Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TP05 in active ulcerative colitis
NCT01903252Phase 3Completed
- Sponsor
- Tillotts Pharma AG
- Start
- Jul 2013
- Primary completion
- May 2016
- Countries
- 1
01
Overview
A Phase 3 trial of mesalamine in ulcerative colitis (UC), sponsored by Tillotts Pharma AG. Started Jul 2013; status: completed.
02
Drugs
mesalamine
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT01903252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01903252.